SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera") ...
Today, the main question in global trade is not about what people want to buy. It is about what the system tolerates.
Rare earth projects require a solid commitment across political cycles, a challenge that the United States has not yet been able to overcome.
SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical ...
As the clock ticks down to an 18 June showdown at a Genco shareholders meeting, Greek owners Semiramis Paliou and Petros ...
The men's big and tall retailer is in the midst of merging with FullBeauty Brands, another extended sizes retailer.
NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines that address significant unmet needs, ...
Humanoid robots are not yet seeing commercial workforce deployment at scale, but strong growth is forecast during the 2030s.
Compare top AI app builders for prototyping, mobile apps, internal tools, backend depth, security, pricing, and code portability.
Asia Pacific consumers are warming to agentic AI faster than brands may be ready for, but a widening trust and execution gap is threatening to slow down adoption at scale.
Polaryx Therapeutics, Inc. (the “Company” or “Polaryx”) (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage ...
The Bank for International Settlements (BIS) has recently shared seemingly promising results and key research findings from Project Agorá, highlighting how tokenization of central bank reserves and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results